abstract |
The present invention relates to a selection of compounds of formula (I): compositions comprising such compounds; in treatment of such compounds (eg in the treatment or prevention of diseases or conditions in which plasma kallikrein activity is involved). Uses; and methods of treating a patient with such compounds, wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein. ]I will provide a. |